| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
| ABSTRACT |
|---|
|
|
|---|
H2AX). X-rays induced the same level of DNA breakage for all cell lines. By 8 hours after 20 Gy, <2% of the initial single-strand breaks remained and no double-strand breaks could be detected. In contrast, 24 hours after irradiation,
H2AX representing up to 30% of the initial signal still present. SW756 cells showed almost four times higher background levels of
H2AX and no residual
H2AX compared with the most radiosensitive HPV-negative C33A cells that showed the lowest background and retained 30% of the maximum level of
H2AX. Radiation sensitivity, measured as clonogenic-surviving fraction after 2 Gy, was correlated with the fraction of
H2AX remaining 24 hours after irradiation. A substantial correlation with
H2AX loss half-time measured over the first 4 hours was seen only when cervical cell lines were included in a larger series of p53-deficient cell lines. Interestingly, p53 wild-type cell lines consistently showed faster
H2AX loss half-times than p53-deficient cell lines. We conclude that cell line-dependent differences in loss of
H2AX after irradiation are related in part to intrinsic radiosensitivity. The possibility that the presence of
H2AX foci may not always signify the presence of a physical break, notably in some tumor cell lines, is also supported by these results. | INTRODUCTION |
|---|
|
|
|---|
H2AX) foci to locate one double-strand break per nucleus has introduced new possibilities for low-level DNA damage detection, analysis of repair enzyme recruitment, and development of predictive assays for tumor response.
The rate of loss of foci and the presence of residual foci has been correlated with cellular radiosensitivity (11
, 12)
. Using 10 unrelated tumor and normal cultured cell lines, we previously observed a correlation between
H2AX loss in the first few hours following irradiation and relative sensitivity to killing by ionizing radiation (11)
. To determine whether the correlation might be improved, a series of cell lines of the same type was used, namely six human cervical carcinoma cell lines. Two of these cell lines, Caski and SW756, showed very high background levels of
H2AX foci, and substantial amounts of residual
H2AX were present in most of the cell lines 24 hours after irradiation. To determine whether foci were indicative of unrepaired strand breaks, the comet assay was used to examine these cell lines for induction and rejoining of DNA strand breaks.
| MATERIALS AND METHODS |
|---|
|
|
|---|
H2AX loss half-time and clonogenicity were also measured for a series of human tumor and normal cell lines, some of which have been reported previously (11)
. These include WiDr human colon carcinoma, A549 lung carcinoma, Du145 prostate carcinoma, HT144 melanoma, WIL2NS lymphoblastoid, U87 glioma, and HCC1937 breast cancer cell lines. In addition to these cell lines, M059J and M059K glioma cells were obtained from American Type Culture Collection. Cell lines with wild-type p53 included A549 and U87 cells from American Type Culture Collection, TK6 cells from Dr. Helen Evans, and two normal primary skin fibroblast cell lines established in our lab. A p53-positive fibroblast line deficient in Ataxia Telangiectasia Mutated (ATM) (AT3BI) and BR3 normal fibroblasts were obtained from Dr. Colin Arlett. Primary human umbilical endothelial cells were obtained from Dr. Aly Karsan.
X-Irradiation.
Cells were irradiated in suspension in glass spinner culture vessels containing MEM plus 10% fetal bovine serum. Irradiation was performed with a 250 kV X-ray unit at a dose rate of 4.7 Gy/minute. Samples were obtained at the indicated recovery times after irradiation (on ice), fixed in 70% ethanol and stored at 20°C until analysis for
H2AX. Alternatively, comet assay was used to examine samples immediately for strand breaks.
Flow Cytometry and Immunohistochemistry for
H2AX.
Staining for
H2AX was conducted as described previously (7)
. Briefly, fixed cells were rehydrated for 10 minutes, centrifuged, and resuspended in 200 µL mouse monoclonal anti-phosphohistone H2AX antibody (1:500 dilution, Upstate Biotechnology Inc., Waltham, MA). Cells were incubated for 2 hours at room temperature, rinsed, and resuspended in 200 µL secondary antibody, Alexa 488 goat antimouse IgG (H + L)F(ab')2 fragment conjugate (1:200 dilution, Molecular Probes) for 1 hour at room temperature. A Coulter Elite cell sorter (Coulter, Fullerton, CA) was used to measure
H2AX and DNA content after rinsing and resuspending cells in 1 µg/ml 4',6-diamidino-2-phenylindole dihydrochloride hydrate (Sigma-Aldrich, St. Louis, MO). WinList software (Verity Software, Topsham, ME) was used to conduct analysis of flow cytometry data. Samples were gated on 4',6-diamidino-2-phenylindole dihydrochloride hydrate for DNA content and time of flight to eliminate debris and cell doublets before analysis of
H2AX antibody staining intensity. In some cases, only late S-G2 phase cells were analyzed. Apoptotic cells, based on a typical 10-fold increase in H2AX phosphorylation (13)
, were also eliminated from analysis of
H2AX loss kinetics. Intensity, in arbitrary units, was expressed relative to the control (untreated) cell population.
Alkaline and Neutral Comet Assays.
An overnight alkaline lysis method at 5°C was used as described previously (14)
to perform the alkaline comet assay and to maximize resolution of radiation-induced strand breaks and alkali-labile sites. Damage remaining 24 hours after irradiation was taken to represent unrepairable single-strand and double-strand breaks. An overnight lysis (22 hours) at 50°C followed by 3 rinses for 30 minutes at room temperature and staining for 30 minutes with propidium iodide was used as described previously (15)
to perform the neutral comet assay. Approximately 150 comet images were obtained and analyzed for each dose and time, and experiments were repeated 2 to 3 times. Mean comet tail moment and SD are presented.
| RESULTS |
|---|
|
|
|---|
H2AX foci. SW756 and Caski cells showed high endogenous levels of expression of
H2AX relative to the other cell lines (Table 1)
50 foci per cell. The high plating efficiency of this cell line (67 ± 4%) indicates that most of the cells with large numbers of
H2AX foci are clonogenic. When flow cytometry was used for analysis, comparable differences in
H2AX were also apparent, and untreated SW756 cells expressed almost four times more
H2AX than the HPV-negative C33A cell line. For the majority of cell lines, 20 to 30% of the cells showed foci. These foci, generally quite small, could be a result of
H2AX expression at endogenous breaks produced transiently during replication and are consistent with our previous elutriation and flow cytometry results describing S-G2phase increases in
H2AX (13)
.
|
|
|
H2AX level was still 10 times background at this time (Fig. 2B)
|
|
H2AX was cell-line dependent. HeLa cells, known to contain low amounts of histone H2AX (4)
, exhibited the smallest slope when measured at the peak expression time of 1 hour (Fig. 3A)
H2AX measured 1 hour after irradiation. Regardless of these differences, the slopes of the
H2AX dose-response curves at 1 hour were unrelated to intrinsic radiosensitivity.
Image analysis was used to examine cells for remaining foci 24 hours after 2 Gy. Typical appearances of untreated cells and cells examined 24 hours after irradiation are shown in Fig. 4
. Assuming one
H2AX focus for each double-strand break, 2 Gy should produce
50 foci per cell, depending on DNA content. For SW756 cells, all cells still contained foci 24 hours after irradiation (Table 2)
, but the high background level of
H2AX makes it difficult to determine whether there are actually residual radiation-induced foci in this cell line. In fact, the average number of foci decreased, although average foci size appeared to increase. The number of foci per cell was not significantly greater 24 hours after 2 Gy compared with controls; however, the number of cells with foci generally increased in all cell lines (Table 2)
. Interestingly, daughter cell pairs identified as two isolated cells with touching nuclei 24 hours after 2 Gy invariably showed similar foci numbers and sizes, a result that was confirmed when cytochalasin D was used to inhibit cell separation after mitosis (data not shown).
|
H2AX measured at the peak time of 1 hour (Fig. 3A)
H2AX was determined from data obtained after exposure of cell lines to 5 to 50 Gy with
H2AX levels measured from 1 to 4 hours after irradiation (Fig. 5)
H2AX loss half-time was found when the six cervical cell lines were included within a larger series of human tumor cells (Fig. 6B)
H2AX after irradiation compared with cell lines deficient in p53 (Fig. 6A)
|
|
H2AX remained in C33A cells (Table 2)
H2AX 24 hours after irradiation. A weak correlation (r2 = 0.59) was found between SF2 and the fraction of residual
H2AX measured as the ratio of slopes at 1 and 24 hours after irradiation for the six cell lines (Fig. 6C)
H2AX in the SW756 cells is likely to interfere with accurate measurement of residual damage. The correlation coefficient without this cell line increased to 0.75. | DISCUSSION |
|---|
|
|
|---|
In contrast to results in which the comet assay was used, induction of
H2AX was cell line dependent. The observation has been made previously that tumor cells vary in expression of H2AX (1)
and the number of radiation-induced foci will also depend on DNA content and kinase activity. The location of the H2AX gene in a chromosomal region frequently altered in cancers (9)
may also contribute to the 3-fold range of initial responses seen in Fig. 3A
. However, the amount of initial induction of
H2AX, or the background expression of
H2AX was unrelated to radiation sensitivity. Also, unlike the comet assay results, substantial amounts of
H2AX were still present in most cell lines 24 hours after irradiation. For the C33A cell line, damage equivalent to 3 Gy (about 75 breaks) was present 24 hours after 10 Gy. This amount of damage should be within the detection limit of the neutral and alkaline comet assays (Fig. 3)
. The inability of the comet assay to detect any residual damage 24 hours after even 20 Gy suggests that many residual foci may not be associated with a physical break. This is perhaps not surprising considering the high background levels of these foci within some tumor cell lines that cannot be explained by high S-phase content, low-plating efficiency, or a high level of background damage in the comet assays. Moreover,
H2AX foci were shown to persist through cell division producing patterns reminiscent of the "mirror-like similarity of chromosome territories" seen in daughter cell pairs (23)
. The similar patterns of
H2AX in daughter cells suggest the intriguing possibility that breaks or chromatin structural changes that act as signals for ATM activation and subsequent H2AX phosphorylation might be inherited.
HPV viral E6 protein effectively inactivates p53 function through binding, which leads to degradation of p53 via the ubiquitin-proteosome system. Five of the six cell lines express HPV and the one exception, C33A, contains a mutated p53 (24)
. The presence of mutant p53 has been associated with decreased cell killing and decreased local tumor control following radiation (25)
. Interestingly, C33A showed the lowest level of background foci (Table 1)
. Duensing and Munger (26)
also reported that expression of HPV-16 E7 protein in normal human keratinocytes was associated with an increase in the fraction of cells with
H2AX foci that could not be accounted for by apoptosis. Cells containing functional p53 lose foci faster than cells lacking p53 following irradiation. Of some importance, the correlation between SF2 and
H2AX loss half-time was only evident when cells were analyzed according to p53 status. When 10 cell lines, representing rodent and human as well as p53-wild-type and p53-deficient cells, were used previously, they showed a good correlation (r2 = 0.7) between SF2 and rate of loss of
H2AX measured between 1 and 4 hours after irradiation. However, results in Fig. 6
for a larger series of p53-wild-type and p53-deficient human cell lines indicate that p53 status appears to be relevant to
H2AX loss rate after irradiation. A possible explanation for the p53 effect is related to its ability to transactivate genes involved in apoptosis; p53-positive cells with high levels of
H2AX could undergo apoptosis, and loss rate might then appear faster. However, loss half-time was measured over the first 4 hours when little apoptosis was apparent, and many of the cell lines were fibroblasts and resistant to apoptosis. Transcription of dozens of genes is regulated by p53, and these might influence
H2AX formation or loss (27)
. Alternatively, functions of p53 unrelated to transcriptional activation may be responsible. p53 has been implicated in nucleotide excision repair and homologous recombination through interactions with Rad51 as well as other repair proteins in this pathway (28
, 29)
. Perhaps lack of p53 influences the repair process by reducing accurate rejoining, and mis-rejoined breaks cause longer retention of foci. Alternatively, chromatin conformational changes appear to influence p53 function (30)
just as they influence activation of ATM (31)
, the kinase that phosphorylates both H2AX and p53. Changes in chromatin structure at sites of misrepair may affect p53 function locally (30)
, and it has been suggested that mutant p53 might modulate nuclear structure and function (32)
. Finally, it is also possible that p53 may be only indirectly involved, and genomic instability subsequent to loss of p53 could produce additional changes that alter foci retention. Experiments are in progress with isogenic cell lines to try to resolve this question.
In summary, induction and rejoining of radiation-induced strand breaks were the same for six cervical cancer cell lines that varied in radiation sensitivity. Phosphorylation of histone H2AX at sites of radiation-induced strand breaks was cell line dependent. Although background expression of
H2AX and induction of foci in response to radiation showed no obvious relationship with radiosensitivity, the residual level of
H2AX measured 24 hours after irradiation was correlated with SF2. Results also identify a role for the tumor suppressor p53 in
H2AX loss rate and they question the assumption that background or residual
H2AX foci are necessarily associated with unrejoined double-strand breaks.
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Requests for reprints: Peggy L. Olive, Medical Biophysics Department, British Columbia Cancer Research Centre, 601 W. 10th Ave., Vancouver, BC V5Z 1L3 Canada. Phone: 604-877-6000, ext. 3024; Fax: 604-877-6002; E-mail: polive{at}bccancer.bc.ca
Received 4/29/04. Revised 6/22/04. Accepted 7/22/04.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. M. McCord, M. Jamal, E. S. Williams, K. Camphausen, and P. J. Tofilon CD133+ Glioblastoma Stem-like Cells are Radiosensitive with a Defective DNA Damage Response Compared with Established Cell Lines Clin. Cancer Res., August 15, 2009; 15(16): 5145 - 5153. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Asaithamby and D. J. Chen Cellular responses to DNA double-strand breaks after low-dose {gamma}-irradiation Nucleic Acids Res., July 1, 2009; 37(12): 3912 - 3923. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iwasa, I. Okamoto, M. Suzuki, T. Nakahara, K. Yamanaka, E. Hatashita, Y. Yamada, M. Fukuoka, K. Ono, and K. Nakagawa Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non-Small Cell Lung Cancer Cell Lines Clin. Cancer Res., October 15, 2008; 14(20): 6496 - 6504. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Rube, S. Grudzenski, M. Kuhne, X. Dong, N. Rief, M. Lobrich, and C. Rube DNA Double-Strand Break Repair of Blood Lymphocytes and Normal Tissues Analysed in a Preclinical Mouse Model: Implications for Radiosensitivity Testing Clin. Cancer Res., October 15, 2008; 14(20): 6546 - 6555. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kinner, W. Wu, C. Staudt, and G. Iliakis {gamma}-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin Nucleic Acids Res., October 1, 2008; 36(17): 5678 - 5694. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Cai, Z. Chen, K. E. Bailey, D. A. Scollard, R. M. Reilly, and K. A. Vallis Relationship Between Induction of Phosphorylated H2AX and Survival in Breast Cancer Cells Exposed to 111In-DTPA-hEGF J. Nucl. Med., August 1, 2008; 49(8): 1353 - 1361. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Huang, Z.-H. Miao, H. Zhu, Y.-J. Cai, W. Lu, and J. Ding Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins Mol. Cancer Ther., June 1, 2008; 7(6): 1440 - 1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. McKenna, S. R. McKeown, and V. J. McKelvey-Martin Potential use of the comet assay in the clinical management of cancer Mutagenesis, May 1, 2008; 23(3): 183 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tanaka, A. Munshi, C. Brooks, J. Liu, M. L. Hobbs, and R. E. Meyn Gefitinib Radiosensitizes Non-Small Cell Lung Cancer Cells by Suppressing Cellular DNA Repair Capacity Clin. Cancer Res., February 15, 2008; 14(4): 1266 - 1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Lally, G. A. Geiger, S. Kridel, A. E. Arcury-Quandt, M. E. Robbins, N. D. Kock, K. Wheeler, P. Peddi, A. Georgakilas, G. D. Kao, et al. Identification and Biological Evaluation of a Novel and Potent Small Molecule Radiation Sensitizer via an Unbiased Screen of a Chemical Library Cancer Res., September 15, 2007; 67(18): 8791 - 8799. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Despras, P. Pfeiffer, B. Salles, P. Calsou, S. Kuhfittig-Kulle, J. F. Angulo, and D. S.F. Biard Long-term XPC Silencing Reduces DNA Double-Strand Break Repair Cancer Res., March 15, 2007; 67(6): 2526 - 2534. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, M. Tseng, S. A. Perdreau, F. Rossi, C. Antonescu, P. Besmer, J. A. Fletcher, S. Duensing, and A. Duensing Histone H2AX Is a Mediator of Gastrointestinal Stromal Tumor Cell Apoptosis following Treatment with Imatinib Mesylate Cancer Res., March 15, 2007; 67(6): 2685 - 2692. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Smilenov, E. J. Hall, W. M. Bonner, and O. A. Sedelnikova A microbeam study of DNA double-strand breaks in bystander primary human fibroblasts Radiat Prot Dosimetry, December 1, 2006; 122(1-4): 256 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dote, W. E. Burgan, K. Camphausen, and P. J. Tofilon Inhibition of hsp90 compromises the DNA damage response to radiation. Cancer Res., September 15, 2006; 66(18): 9211 - 9220. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gallmeier, J. M. Winter, S. C. Cunningham, S. R. Kahn, and S. E. Kern Novel genotoxicity assays identify norethindrone to activate p53 and phosphorylate H2AX Carcinogenesis, October 1, 2005; 26(10): 1811 - 1820. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liu, Y. Guo, Y. Li, Y. Jiang, S. Chubb, A. Azuma, P. Huang, A. Matsuda, W. Hittelman, and W. Plunkett Molecular Basis for G2 Arrest Induced by 2'-C-Cyano-2'-Deoxy-1-{beta}-D-Arabino-Pentofuranosylcytosine and Consequences of Checkpoint Abrogation Cancer Res., August 1, 2005; 65(15): 6874 - 6881. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rodel, J. Hoffmann, L. Distel, M. Herrmann, T. Noisternig, T. Papadopoulos, R. Sauer, and C. Rodel Survivin as a Radioresistance Factor, and Prognostic and Therapeutic Target for Radiotherapy in Rectal Cancer Cancer Res., June 1, 2005; 65(11): 4881 - 4887. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |